Details

Guidance Policy - Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research Policy (POL-0053) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 3, 2026 · edition #6
Timestamp: 2026-01-03T18:07:00.461Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-6/20260103180700/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=false#ha_snapshot=448964
ID: 448964
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots